Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Free Cash Flow (2016 - 2025)

BioCorRx (BICX) has disclosed Free Cash Flow for 16 consecutive years, with -$847722.0 as the latest value for Q4 2025.

  • Quarterly Free Cash Flow fell 242.97% to -$847722.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.3 million through Dec 2025, down 109.65% year-over-year, with the annual reading at -$2.3 million for FY2025, 109.65% down from the prior year.
  • Free Cash Flow hit -$847722.0 in Q4 2025 for BioCorRx, down from -$634447.0 in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$126499.0 in Q2 2025 to a low of -$1.3 million in Q2 2021.
  • Historically, Free Cash Flow has averaged -$541463.8 across 5 years, with a median of -$491706.0 in 2022.
  • Biggest five-year swings in Free Cash Flow: surged 73.72% in 2022 and later crashed 242.97% in 2025.
  • Year by year, Free Cash Flow stood at -$647624.0 in 2021, then soared by 30.58% to -$449576.0 in 2022, then decreased by 18.74% to -$533836.0 in 2023, then soared by 53.7% to -$247170.0 in 2024, then plummeted by 242.97% to -$847722.0 in 2025.
  • Business Quant data shows Free Cash Flow for BICX at -$847722.0 in Q4 2025, -$634447.0 in Q3 2025, and -$126499.0 in Q2 2025.